Cannabix Technologies Inc. reported that engineers have developed and deployed new ion optics methods that have resulted in a 6 times increase in analyte signal which has increased the sensitivity in the Company’s FAIMS (field asymmetric waveform ion mobility spectrometry) ?9-tetrahydrocannabinol (“THC”) detection device. The Company has been working for the last several months on improving “ion optics” which is a critical component of the FAIMS system in order to better focus and maximize ion flow through the FAIMS cell “keyhole”. Furthermore, the Company reported that Cannabix scientists have been testing with a single stage, direct breath with the FAIMS device, that allows for real-time collection and analysis of low volatility compounds without sample preparation. In addition, Company engineers have been pushing forward development of its THC Breath Analyzer (“THCBA”) which incorporates microfluidic sensor technology for the detection of ?9-tetrahydrocannabinol (“THC”) from breath. As announced in November, engineers have reduced the size of several components inside the THCBA for a more compact device, over the course of December, engineers have been further optimizing breath sample chamber design and tested additional sensors that work in conjunction with microfluidic sensor.